Skip to main content
Psychopharmacology Bulletin › All Volumes & Issues › VOL 40 No. 2 › Isolated Aripiprazole Drug...
LETTER TO THE EDITOR

Isolated Aripiprazole Drug Interaction with Estrogen

Shaina D. Barnes, Elizabeth A. Winans
Psychopharmacology Bulletin 40(2): 153-154, 2007/05/07; https://doi.org/10.64719/pb.4336

Abstract

Aripiprazole, a partial dopamine (D2) agonist, was introduced to the U.S. market in November of 2002.¹ Aripiprazole has several known drug interactions, predominately related to inhibition of its metabolism via the cytochrome P450 2D6 and 3A4 isoenzyme pathways. To our knowledge, this is the first report of an estrogen/aripipraz

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In
Not yet subscribed? View subscription options

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Shaina D. Barnes, Elizabeth A. Winans. Isolated Aripiprazole Drug Interaction with Estrogen. Psychopharmacology Bulletin. 2007/05/07; 40(2):153-154. https://doi.org/10.64719/pb.4336